Jacques Van Snick
Scientist
Ludwig Center at Brussels
Ludwig Institute for Cancer Research
Belgium
Biography
Development of anti-cytokine auto-vaccination in mice as an alternative to genetic inactivation.Has got his MD from Université catholique de Louvain, Belgium in 1975.He has won various awards including Prix Interbrew-Baillet Latour de la Santé, 2000.
Research Interest
Cancer, Vaccine, signalling
Publications
-
Van Damme, Jozef, et al. "Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor." Journal of Experimental Medicine 165.3 (1987): 914-919.
-
Veldhoen, Marc, et al. "Transforming growth factor-β'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset." Nature immunology 9.12 (2008): 1341-1346.
-
Houssiau, Frédéric A., et al. "Interleukinâ€6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides." Arthritis & Rheumatology 31.6 (1988): 784-788.
